The FDA may have trouble sustaining the Trump administration’s enforcement push on direct-to-consumer (DTC) advertising given the administration’s efforts to reduce and reorganize the federal bureaucracy, according to experts at the recent FDLI Advertising and Promotion Conference. Clint Narver, a partner at McGuire Woods LLP, said while the DTC push has been a “concerted eff... Read More